Heart failure can touch anyone. But for Black and Hispanic people, this condition tends to be more serious and harder to manage. Black and Hispanic people are more likely than white people to need ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA ...

Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

Temporary use of left ventricular assist devices, such as this one, in combination with medications can help restore normal cardiovascular function in some patients with heart failure, according to a ...

In simplest terms, heart failure, or congestive heart failure, occurs when the heart can’t pump enough blood to meet the body’s needs. It’s surprisingly common—about 6.2 million adults in the United ...

Heart failure affects many millions globally but can be caused by multiple factors, requiring different treatments. Now, researchers have trained multiple machine learning models using a large, ...

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...

After securing Medicare reimbursement for its pacemaker-like heart failure (HF) implant, Impulse Dynamics has raised more ...

Dr Pradeep highlights warning signs of heart failure, including increased urination at night, swollen ankles, and ...

These two conditions affect how well your heart can pump blood. Cardiomyopathy can sometimes lead to heart failure. Cardiomyopathy and heart failure are both conditions in which your heart has a more ...

The FDA expanded Furoscix use to certain pediatric patients. ・MannKind received five new U.S. patents supporting its ...